OSIR
Osiris Therapeutics, Inc. Common Stock
OSIR
OSIR
Delisted
OSIR was delisted on the 16th of April, 2019.
67 hedge funds and large institutions have $109M invested in Osiris Therapeutics, Inc. Common Stock in 2014 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 23 increasing their positions, 17 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
less capital invested
Capital invested by funds: $ → $
88% less call options, than puts
Call options by funds: $611K | Put options by funds: $4.91M
Holders
67
Holding in Top 10
–
Calls
$611K
Puts
$4.91M
Top Buyers
| 1 | +$4.34M | |
| 2 | +$671K | |
| 3 | +$587K | |
| 4 |
Group One Trading
Chicago,
Illinois
|
+$489K |
| 5 |
NCCM
Nine Chapters Capital Management
Short Hills,
New Jersey
|
+$400K |
Top Sellers
| 1 | -$4.92M | |
| 2 | -$690K | |
| 3 | -$272K | |
| 4 |
GCP
GSA Capital Partners
London,
United Kingdom
|
-$265K |
| 5 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
-$214K |